Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Genenta Science S.p.A. Unsponsored ADR (GNTA) had Income from Continuous Operations of $-7.39M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-7.39M |
|
-- |
|
-- |
|
$7.47M |
|
$-7.47M |
|
$0.08M |
|
$-7.39M |
|
$-7.39M |
|
$-7.39M |
|
|
Income from Continuous Operations |
$-7.39M |
$-7.39M |
|
$-7.39M |
|
$-7.47M |
|
$-7.44M |
|
19.71M |
|
19.71M |
|
$-0.37 |
|
$-0.37 |
|
| Balance Sheet Financials | |
$33.92M |
|
$0.03M |
|
$2.16M |
|
$36.08M |
|
$2.40M |
|
$8.60M |
|
$8.97M |
|
$11.37M |
|
$24.71M |
|
$24.71M |
|
$24.71M |
|
23.43M |
|
| Cash Flow Statement Financials | |
$-7.77M |
|
$-16.45M |
|
$25.22M |
|
$5.18M |
|
$6.25M |
|
$1.07M |
|
$1.14M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.16 |
|
-- |
|
-- |
|
0.26 |
|
0.35 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.78M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-29.90% |
|
-29.90% |
|
-20.48% |
|
-22.18% |
|
$1.05 |
|
$-0.39 |
|
$-0.39 |
|